NO180196C - Analogifremgangsmåte for fremstilling av terapeutisk aktive amino- og nitroholdige, tricykliske forbindelser - Google Patents

Analogifremgangsmåte for fremstilling av terapeutisk aktive amino- og nitroholdige, tricykliske forbindelser

Info

Publication number
NO180196C
NO180196C NO915068A NO915068A NO180196C NO 180196 C NO180196 C NO 180196C NO 915068 A NO915068 A NO 915068A NO 915068 A NO915068 A NO 915068A NO 180196 C NO180196 C NO 180196C
Authority
NO
Norway
Prior art keywords
preparation
nitro
therapeutically active
hydrogen
active amino
Prior art date
Application number
NO915068A
Other languages
English (en)
Norwegian (no)
Other versions
NO915068D0 (no
NO915068L (no
NO180196B (no
Inventor
Gary Alan Flynn
Douglas Wade Beight
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO915068D0 publication Critical patent/NO915068D0/no
Publication of NO915068L publication Critical patent/NO915068L/no
Publication of NO180196B publication Critical patent/NO180196B/no
Publication of NO180196C publication Critical patent/NO180196C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO915068A 1990-12-21 1991-12-20 Analogifremgangsmåte for fremstilling av terapeutisk aktive amino- og nitroholdige, tricykliske forbindelser NO180196C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63357290A 1990-12-21 1990-12-21
US77762591A 1991-10-23 1991-10-23

Publications (4)

Publication Number Publication Date
NO915068D0 NO915068D0 (no) 1991-12-20
NO915068L NO915068L (no) 1992-06-22
NO180196B NO180196B (no) 1996-11-25
NO180196C true NO180196C (no) 1997-03-05

Family

ID=27091923

Family Applications (1)

Application Number Title Priority Date Filing Date
NO915068A NO180196C (no) 1990-12-21 1991-12-20 Analogifremgangsmåte for fremstilling av terapeutisk aktive amino- og nitroholdige, tricykliske forbindelser

Country Status (18)

Country Link
EP (1) EP0492369B1 (ja)
JP (1) JP3112327B2 (ja)
KR (2) KR100220880B1 (ja)
CN (1) CN1040985C (ja)
AT (1) ATE158303T1 (ja)
AU (1) AU642321B2 (ja)
CA (1) CA2057786C (ja)
DE (1) DE69127681T2 (ja)
DK (1) DK0492369T3 (ja)
ES (1) ES2108027T3 (ja)
FI (1) FI95800C (ja)
GR (1) GR3025622T3 (ja)
HU (1) HU210167B (ja)
IE (1) IE914507A1 (ja)
IL (1) IL100416A (ja)
NO (1) NO180196C (ja)
NZ (1) NZ241023A (ja)
PT (1) PT99849B (ja)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5308841A (en) * 1990-12-21 1994-05-03 Merrell Dow Pharmaceuticals Inc. Amino and nitro containing tricyclic compounds useful as inhibitors of ACE
US5455242A (en) * 1991-09-27 1995-10-03 Merrell Dow Pharmaceuticals Inc. Carboxyalkyl tricyclic derivatives useful as inhibitors of enkephalinase and ace
US5457196A (en) * 1991-09-27 1995-10-10 Merrell Dow Pharmaceuticals Inc. 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE
CA2078759C (en) * 1991-09-27 2003-09-16 Alan M. Warshawsky Novel carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace
DE69220744T2 (de) * 1991-09-27 1997-11-13 Merrell Pharma Inc 2-Substituierte Indan-2-Mercaptoacetylamid-Verbindungen mit Enkephalinase und ACE-Hemmwirkung
AU657793B2 (en) * 1991-09-27 1995-03-23 Merrell Pharmaceuticals Inc. Novel 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE
ES2138622T3 (es) * 1992-05-15 2000-01-16 Merrell Pharma Inc Derivados de mercaptoacetilamido piridazo(1,2-a)(1,2)diazepina utilizados como inhibidores de encefalinasa y eca.
KR100311166B1 (ko) * 1992-10-30 2002-02-28 슈테펜엘.네스비트 신규한머캅토아세틸아미드비사이클릭락탐유도체및이의제조방법
US5362727A (en) * 1993-07-26 1994-11-08 Bristol-Myers Squibb Substituted azepino[2,1-a]isoquinoline compounds
US5525723A (en) * 1993-11-18 1996-06-11 Bristol-Myers Squibb Co. Compounds containing a fused multiple ring lactam
ES2145267T3 (es) * 1994-02-14 2000-07-01 Merrell Pharma Inc Nuevos derivados bisulfuro de mercaptoacetilamido de 1,3,4,5-tetrahidro-benzo(c)azepin-3-ona utiles como inhibidores de la encefalinasa y del enzima de conversion de la angiotensina.
US5530013A (en) * 1994-02-14 1996-06-25 American Home Products Corporation Venlafaxine in the inducement of cognition enhancement
JP3608624B2 (ja) * 1994-02-14 2005-01-12 メレル ファーマスーティカルズ インコーポレーテッド エンケファリナーゼ阻害剤として有用な新規なインダン−２−メルカプトアセチルアミドジスルフィド誘導体類
JP3596778B2 (ja) * 1994-02-14 2004-12-02 メレル ファーマスーティカルズ インコーポレーテッド エンケファリナーゼ及びａｃｅの阻害剤として有用な、新規なメルカプトアセチルアミドジスルフィド誘導体類
CA2183314C (en) * 1994-02-14 1999-08-31 Gary A. Flynn Novel 2-substituted indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
US5484783A (en) * 1994-03-24 1996-01-16 Merrell Dow Pharmaceuticals Inc. Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide and benzazapine derivatives
DE69531489T2 (de) * 1994-03-24 2004-04-08 Merrell Pharmaceuticals Inc., Cincinnati Cholesterin senkende mercaptoacetylamiddisulfidderivate
EP0751783B1 (en) * 1994-03-24 2000-02-02 Merrell Pharmaceuticals Inc. Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic use of aminoacetylmercapto derivatives
US5641880A (en) * 1994-12-21 1997-06-24 Hoechst Marion Roussel, Inc. Processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof
DK0800527T3 (da) * 1994-12-21 2000-06-05 Aventis Pharma Inc Nye fremgangsmåder til fremstilling af mellemprodukter for inhibitorer af enkephalinase og angiotensinomdannende enzym og m
US7078225B2 (en) 2000-06-02 2006-07-18 Nippon Shokubai Co., Ltd. Method for enzymatically producing an optically active cyanohydrin
GB0119305D0 (en) 2001-04-12 2001-10-03 Aventis Pharma Gmbh Mercaptoacetylamide derivatives,a process for their preparation and their use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4584294A (en) * 1984-11-07 1986-04-22 Merck & Co., Inc. Fused tricyclic lactams as angiotensin converting enzyme inhibitors and as antihypertensive agents
CA1337654C (en) * 1986-06-13 1995-11-28 Gary A. Flynn Fused tricyclic lactams as antihypertensive agents
AU636101B2 (en) * 1987-04-10 1993-04-22 Monash University 1,2,3,4,10,14b-hexahydrodibenzo(c,f)pyrazino-(1,2-a)azepino derivatives and 10-aza, 10-oxa and 10-thia analogues
US4824832A (en) * 1987-12-30 1989-04-25 Merrell Dow Pharmaceuticals Inc. Sulfhydryl containing tricyclic lactams and their pharmacological methods of use
CA2053340C (en) * 1990-10-18 2002-04-02 Timothy P. Burkholder Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace

Also Published As

Publication number Publication date
JPH04342588A (ja) 1992-11-30
GR3025622T3 (en) 1998-03-31
CN1040985C (zh) 1998-12-02
KR100220880B1 (ko) 1999-09-15
ES2108027T3 (es) 1997-12-16
PT99849B (pt) 1999-06-30
CN1062729A (zh) 1992-07-15
JP3112327B2 (ja) 2000-11-27
DE69127681D1 (de) 1997-10-23
FI916017A (fi) 1992-06-22
NO915068D0 (no) 1991-12-20
KR920012082A (ko) 1992-07-25
AU642321B2 (en) 1993-10-14
HU914092D0 (en) 1992-03-30
HU210167B (en) 1995-02-28
EP0492369A1 (en) 1992-07-01
FI95800C (fi) 1996-03-25
IL100416A (en) 1995-11-27
NO915068L (no) 1992-06-22
EP0492369B1 (en) 1997-09-17
DE69127681T2 (de) 1998-01-15
PT99849A (pt) 1992-11-30
ATE158303T1 (de) 1997-10-15
CA2057786A1 (en) 1992-06-22
FI916017A0 (fi) 1991-12-19
IL100416A0 (en) 1992-09-06
AU8981991A (en) 1992-06-25
NZ241023A (en) 1994-10-26
HUT60271A (en) 1992-08-28
KR100220879B1 (ko) 2000-03-15
FI95800B (fi) 1995-12-15
IE914507A1 (en) 1992-07-01
CA2057786C (en) 2002-06-18
NO180196B (no) 1996-11-25
DK0492369T3 (da) 1997-10-13

Similar Documents

Publication Publication Date Title
NO180196C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive amino- og nitroholdige, tricykliske forbindelser
AP9701039A0 (en) Derivatives of 2- (2-oxo-ethlidene)-imidazolidin-4-one.
MY107756A (en) Piperazine derivatives.
CA2247443A1 (en) Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma
DK0759899T3 (da) Nitroforbindelser og sammensætninger deraf med antiinflammatoriske, analgetiske og antitrombotiske aktiviteter
TR199601032A2 (tr) Matris metalloprotaz önleyicileri.
AP2003002841A0 (en) Quinazolines as MMP-13 inhibitors
EE200200070A (et) Raku adhesiooni inhibiitorid
NO175256C (no) Analogifremgangsmåte til fremstilling av terapeutisk aktive 4-oksokinolin-3-karboksylsyrederivater
GB0018272D0 (en) Chemical compounds IV
CA2203237A1 (en) Aminotetrazole derivatives useful as nitric oxide synthase inhibitors
ATE120955T1 (de) Benzyliden-malononitril-derivate zur hemmung von proliferativen prozessen in säugetierzellen.
HUP9801072A2 (hu) Szubsztituált 6-és 7-amino-tetrahidro-izokinolin-karbonsav-származékok, ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
ES2073258T3 (es) Nuevos derivados de la urea, su preparacion y su aplicacion en terapeutica.
MXPA04005940A (es) Acidos 3-(imidazolil)-2-aminopropanoicos.
ATE213241T1 (de) Amidin- und isothioharnstoffderivate als inhibitoren der stickstoffoxid-synthase
MXPA99009882A (es) Derivados de amidina como inhibidores de la oxidonitrico sintasa.
AU5296199A (en) Antibacterial agents
NO972731D0 (no) Thiazolidinonforbindelser eller middel inneholdende disse for å behandle eller forhindre angina pectoris
GB1405966A (en) Pharmaceutical compositions
ATE44741T1 (de) 2-(n-substituierte guanidino)-4heteroarylthiazole als mittel gegen geschwuere.
CO4230083A1 (es) Novedosos carbomatos y ureas como modificaciones a la resis- tencia a multiples drogas